ATE219062T1 - Phenylalkyl imidazole derivate als h3 rezeptor liganden - Google Patents

Phenylalkyl imidazole derivate als h3 rezeptor liganden

Info

Publication number
ATE219062T1
ATE219062T1 AT98956442T AT98956442T ATE219062T1 AT E219062 T1 ATE219062 T1 AT E219062T1 AT 98956442 T AT98956442 T AT 98956442T AT 98956442 T AT98956442 T AT 98956442T AT E219062 T1 ATE219062 T1 AT E219062T1
Authority
AT
Austria
Prior art keywords
phenylalkyl
receptor ligands
imidazole derivatives
imidazole
derivatives
Prior art date
Application number
AT98956442T
Other languages
English (en)
Inventor
Robert G Aslanian
Kevin D Mccormick
Mwangi Wa Mutahi
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE219062T1 publication Critical patent/ATE219062T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
AT98956442T 1997-11-07 1998-11-05 Phenylalkyl imidazole derivate als h3 rezeptor liganden ATE219062T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96634497A 1997-11-07 1997-11-07
US12971198A 1998-08-05 1998-08-05
PCT/US1998/023223 WO1999024405A1 (en) 1997-11-07 1998-11-05 H3 receptor ligands of the phenyl-alkyl-imidazoles type

Publications (1)

Publication Number Publication Date
ATE219062T1 true ATE219062T1 (de) 2002-06-15

Family

ID=26827847

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98956442T ATE219062T1 (de) 1997-11-07 1998-11-05 Phenylalkyl imidazole derivate als h3 rezeptor liganden

Country Status (18)

Country Link
EP (1) EP1028947B8 (de)
JP (1) JP2001522835A (de)
KR (1) KR20010031724A (de)
CN (1) CN1130349C (de)
AR (1) AR016672A1 (de)
AT (1) ATE219062T1 (de)
AU (1) AU1296699A (de)
CA (1) CA2308586A1 (de)
CO (1) CO5011065A1 (de)
DE (1) DE69806042T2 (de)
ES (1) ES2174510T3 (de)
HK (1) HK1025968A1 (de)
HU (1) HUP0004292A3 (de)
IL (1) IL135729A0 (de)
NZ (1) NZ504124A (de)
PE (1) PE134399A1 (de)
TW (1) TW421645B (de)
WO (1) WO1999024405A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20020507A1 (es) 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
JP4522651B2 (ja) 2001-03-13 2010-08-11 シェーリング コーポレイション 新規非イミダゾール化合物
PL374758A1 (en) * 2002-10-24 2005-10-31 Merck Patent Gmbh Methylene urea derivatives
WO2006076706A1 (en) 2005-01-14 2006-07-20 Millennium Pharmaceuticals, Inc. Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity
EP1749523A1 (de) * 2005-07-29 2007-02-07 Neuropharma, S.A. GSK-3 Inhibitoren
EP1931665A1 (de) 2005-09-20 2008-06-18 Schering Corporation Als histamin-h3-antagonist geeignetes 1-[[1-[(2-amin0-6-methyl-4-pyridinyl)methyl]-4-fluor-4-piperidinyl]carbonyl]-4-[2-(2-pyridinyl)-3h-imidazo[4,5-b]pyridin-3-yl]piperidin
JP2015530378A (ja) * 2012-08-29 2015-10-15 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 変形性関節症の処置のためのｄｄｒ２インヒビター

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686084B1 (fr) * 1992-01-10 1995-12-22 Bioprojet Soc Civ Nouveaux derives de l'imidazole, leur preparation et leurs applications therapeutiques.
ATE234290T1 (de) * 1993-11-15 2003-03-15 Schering Corp Phenylalkyl-imidazole als h3-rezeptor- antagonisten
FR2732017B1 (fr) * 1995-03-21 2000-09-22 Inst Nat Sante Rech Med Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques
WO1998006394A1 (en) * 1996-08-16 1998-02-19 Schering Corporation Treatment of upper airway allergic responses with a combination of histamine receptor antagonists

Also Published As

Publication number Publication date
EP1028947A1 (de) 2000-08-23
ES2174510T3 (es) 2002-11-01
AU1296699A (en) 1999-05-31
NZ504124A (en) 2002-10-25
AR016672A1 (es) 2001-07-25
EP1028947B8 (de) 2004-01-28
TW421645B (en) 2001-02-11
PE134399A1 (es) 2000-01-10
CN1285822A (zh) 2001-02-28
IL135729A0 (en) 2001-05-20
WO1999024405A1 (en) 1999-05-20
EP1028947B1 (de) 2002-06-12
HUP0004292A3 (en) 2001-12-28
DE69806042T2 (de) 2003-01-23
HK1025968A1 (en) 2000-12-01
JP2001522835A (ja) 2001-11-20
KR20010031724A (ko) 2001-04-16
CA2308586A1 (en) 1999-05-20
CO5011065A1 (es) 2001-02-28
DE69806042D1 (de) 2002-07-18
HUP0004292A2 (hu) 2001-11-28
CN1130349C (zh) 2003-12-10

Similar Documents

Publication Publication Date Title
ATE253067T1 (de) Diazabicyloderivate als nikotin-acetylcholin- rezeptorliganden
DE60331444D1 (de) 1h-1,2,4- triazol-3- carboxamid derivate als cannabinoid-cb1 receptor liganden
DE69605430T2 (de) Chinolin-2-on derivate als serotonin antagonisten
DE69841138D1 (de) Imidazolderivate als mdr-modulatoren
DE69628334D1 (de) Chinolin derivate als nk3 antagoniste
ATE349440T1 (de) Als antikrebsmittel verwendbare heterocyklische derivate
DE60023167D1 (de) Pyrazol-derivate als cannabinoidrezeptor-antagonisten
ATE290001T1 (de) Neue substituierte imidazolverbindungen
DE69921124D1 (de) Imidazolderivate und ihre verwendung als somatostatin rezeptorliganden
ATE216999T1 (de) Pyrimidin-4-on derivate als pestizidesmittel
ATE386024T1 (de) Arylkondensierte azapolycyclische derivate
DE69817792D1 (de) 16-hydroxy-11-(substituierte phenyl)-estra-4,9-dien derivate
DE69714265T2 (de) Tetrahydrochinolinderivate als eaa antagonisten
DE69819903D1 (de) Bizyklische verbindungen als liganden der 5-ht1 rezeptoren
DE69928262D1 (de) Substituierte chinazoline derivate
DE69806042D1 (de) Phenylalkyl imidazole derivate als h3 rezeptor liganden
DE69811110T2 (de) Phenyl-alkyl imidazole als h3 rezeptor antagonisten
DE69926632D1 (de) Tetrahydrochinolinderivate als glycin antagonisten
ATE196766T1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor- antagonisten
DE69805974D1 (de) 5-aroylnaphthalin derivate
ATE228514T1 (de) Indolin-derivate verwendbar als 5-ht-2c rezeptor- antagonisten
DE69527785D1 (de) Chinuclidin-n-oxidderivate als muscarin rezeptor liganden
ATE208764T1 (de) Isazole derivate als fibrinogen-rezeptor- antagonisten
DE69838303D1 (de) Hydroxyprolin derivate
DE60012953D1 (de) 3-amino-2-phenylpiperidinderivate als substanz p antagonisten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties